150 related articles for article (PubMed ID: 15804702)
1. Autoantibodies to heterogeneous nuclear ribonucleoproteins.
Caporali R; Bugatti S; Bruschi E; Cavagna L; Montecucco C
Autoimmunity; 2005 Feb; 38(1):25-32. PubMed ID: 15804702
[TBL] [Abstract][Full Text] [Related]
2. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
[TBL] [Abstract][Full Text] [Related]
3. [Autoantibodies to the heterogeneous nuclear ribonucleoproteins and the autoimmune diseases].
Yang L; Yu M; Yang C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):311-4. PubMed ID: 12567457
[TBL] [Abstract][Full Text] [Related]
4. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
5. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
Kim JH; Hahm B; Kim YK; Choi M; Jang SK
J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
Steiner G; Skriner K; Smolen JS
Int Arch Allergy Immunol; 1996 Dec; 111(4):314-9. PubMed ID: 8957102
[TBL] [Abstract][Full Text] [Related]
7. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
[TBL] [Abstract][Full Text] [Related]
8. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
[TBL] [Abstract][Full Text] [Related]
9. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.
Montecucco C; Caporali R; Cobianchi F; Biamonti G
Arthritis Rheum; 1996 Oct; 39(10):1669-76. PubMed ID: 8843857
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
Steiner G; Skriner K; Hassfeld W; Smolen JS
Mol Biol Rep; 1996; 23(3-4):167-71. PubMed ID: 9112225
[TBL] [Abstract][Full Text] [Related]
11. The I protein of the heterogeneous nuclear ribonucleoprotein complex is a novel dog nuclear autoantigen.
Soulard M; Della Valle V; Monod G; Prélaud P; Lacroix JC; Larsen CJ
J Autoimmun; 1996 Oct; 9(5):599-608. PubMed ID: 8933275
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.
Sueoka E; Yukitake M; Iwanaga K; Sueoka N; Aihara T; Kuroda Y
Ann Neurol; 2004 Dec; 56(6):778-86. PubMed ID: 15497154
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNA.
De Beéck KO; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Rheumatology (Oxford); 2012 Aug; 51(8):1515-6. PubMed ID: 22661555
[No Abstract] [Full Text] [Related]
14. Antibodies to hnRNP core protein A1 in connective tissue diseases.
Astaldi Ricotti GC; Bestagno M; Cerino A; Negri C; Caporali R; Cobianchi F; Longhi M; Maurizio Montecucco C
J Cell Biochem; 1989 May; 40(1):43-7. PubMed ID: 2745573
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous nuclear ribonucleoproteins (hnRNPs): an emerging family of autoantigens in rheumatic diseases.
Biamonti G; Ghigna C; Caporali R; Montecucco C
Clin Exp Rheumatol; 1998; 16(3):317-26. PubMed ID: 9631758
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein complexes from Xenopus laevis oocytes and somatic cells.
Marcu A; Bassit B; Perez R; Piñol-Roma S
Int J Dev Biol; 2001 Sep; 45(5-6):743-52. PubMed ID: 11669376
[TBL] [Abstract][Full Text] [Related]
17. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production.
Greidinger EL; Gazitt T; Jaimes KF; Hoffman RW
Arthritis Rheum; 2004 Jul; 50(7):2216-22. PubMed ID: 15248220
[TBL] [Abstract][Full Text] [Related]
18. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.
Steiner G; Hartmuth K; Skriner K; Maurer-Fogy I; Sinski A; Thalmann E; Hassfeld W; Barta A; Smolen JS
J Clin Invest; 1992 Sep; 90(3):1061-6. PubMed ID: 1522214
[TBL] [Abstract][Full Text] [Related]
19. Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome.
Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):733-8. PubMed ID: 14528909
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods.
Heegaard NH; Larsen MR; Muncrief T; Wiik A; Roepstorff P
Arthritis Res; 2000; 2(5):407-14. PubMed ID: 11056675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
